Rahul Anil Pandit

Rahul Anil Pandit

Active Director Director DIN 06810755
DIN 06810755 First appointment Mar 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Past companies 2 historical roles
Total affiliations 10 Since Mar 2014
Shareholding value •••• Premium profile

About Rahul Anil Pandit

Data last updated:

Rahul Anil Pandit is a Director at Procare Health Advisors Private Limited (since 2019), Director at Maharashtra Biodesign Institute (since 2026) and Director at Biolytics Technologies Private Limited (since 2024), and holds 5 more current directorships. The companies operate in Healthcare and Research & Development. The largest current company by reported revenue is Procare Health Advisors Private Limited at ₹7.45 Cr (FY 2025). Earlier, Rahul Anil Pandit was a Designated Partner at Krimson Micus Critical Care Llp (from 2015) and Partner at Zen Kart Solutions Llp (from 2015).

DIN 06810755
Primary Designation Director
Industry Healthcare
First Appointment 03 Mar 2014
Oldest Company Age 12 yrs
Largest company Procare Health Advisors Private Limited · ₹7.45 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20192019₹7.45 Cr (FY 2025)Active
Maharashtra Biodesign Institute U72100MH2026NPL473383
Director11 Jul 20262026Active
Director17 Dec 20242024Active
Critical Care Nephrology Association U94120MH2024NPL420085
Director27 Feb 20242024Active
Tele Critical Care Association U94120MH2024NPL416827
Director05 Jan 20242024Active
Lucidum Digimed Private Limited U73100MH2019PTC332910
Director14 Nov 20192019Active
Indian Air Hospital Private Limited U85191MH2015PTC263992
Director08 Jun 20152015Active
Designated Partner03 Mar 20142014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Feb 20152015Strike Off
Partner12 May 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lucidum Digimed Private Limited
Indian Air Hospital Private Limited
Procare Health Advisors Private Limited
Krimson Micus Critical Care Llp
Premium access

Shareholding and investment profile for Rahul Anil Pandit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Anil Pandit

Rahul Anil Pandit currently holds 8 directorships: Procare Health Advisors Private Limited (Director, since 04 Jul 2019, revenue ₹7.45 Cr (FY 2025)); Maharashtra Biodesign Institute (Director, since 11 Jul 2026); Biolytics Technologies Private Limited (Director, since 17 Dec 2024); Critical Care Nephrology Association (Director, since 27 Feb 2024); Tele Critical Care Association (Director, since 05 Jan 2024); and 3 more.

Rahul Anil Pandit was first appointed on 03 Mar 2014 as Designated Partner at Mumbai Icu Specialist Llp. The most recent appointment on record is 11 Jul 2026 at Maharashtra Biodesign Institute.

Rahul Anil Pandit held 2 earlier board appointments: Krimson Micus Critical Care Llp (Designated Partner, from 18 Feb 2015); Zen Kart Solutions Llp (Partner, from 12 May 2015).

The current boards of Rahul Anil Pandit's companies include Rizwan Ahmad Rayees Ahmad Shaikh (Procare Health Advisors Private Limited), Shrikant Ganapati Kamath (Procare Health Advisors Private Limited), Abhijit Arvind Deshpande (Maharashtra Biodesign Institute), Ashutosh Arvind Deshpande (Maharashtra Biodesign Institute), Arindam Kar (Critical Care Nephrology Association), Choudhuri Sudhiranjan Dash (Critical Care Nephrology Association), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available